Moving from recommendation to implementation and audit: Part 1

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
K. Kümmerer, A. Henninger  Clinical Microbiology and Infection 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Rapid streptococcal testing for sore throat and antibiotic resistance
Approach to diagnosis of infective endocarditis
Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.
Herpes zoster in non-hospitalized children
K. Kümmerer, A. Henninger  Clinical Microbiology and Infection 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties  J. Maugein, D. Guillemot, M.J. Dupont, T. Fosse,
R. Cantón  Clinical Microbiology and Infection 
Didier Guillemot, Claude Carbon  Clinical Microbiology and Infection 
Rapid streptococcal testing for sore throat and antibiotic resistance
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
P. Davey, C. Pagliari, A. Hayes  Clinical Microbiology and Infection 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
Cephalosporins: a pharmacological update
Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever?  S. Edouard, A. Michel-Lepage, D. Raoult 
D. Esel, B. Sümerkan, S. Kocagöz  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
Elements of design: the knowledge on which we build
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
G.R. Davies  Clinical Microbiology and Infection 
Pathogenesis of catheter-related infections: lessons for new designs
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in eastern France  Daniel Talon, Blandine Mulin, Marie-Jeanne Dupont, Anne-Marie.
D. Felmingham, C. Feldman, W. Hryniewicz, K. Klugman, S. Kohno, D. E
Antibacterial drug discovery in the 21st century
Community-acquired pneumonia: epidemiologic and clinical consideration
Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou, China, from 2006 to 2009  Y. Jin,
Abstracts cont. Clinical Microbiology and Infection
Abstracts cont. Clinical Microbiology and Infection
Reducing antibiotic use in influenza: challenges and rewards
Clinical infection services—the Leiden experience
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Clinical Microbiology and Infection
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
Overview of cefixime use in community-acquired infections
Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France  D.
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
Carratalà J.   Clinical Microbiology and Infection 
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis  Bernard Grenier  Clinical.
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
The future of diagnostic bacteriology
Presentation transcript:

Moving from recommendation to implementation and audit: Part 1 Moving from recommendation to implementation and audit: Part 1. Current recommendations and programs: a critical commentary  C. Carbon, O. Cars, K. Christiansen  Clinical Microbiology and Infection  Volume 8, Pages 92-106 (January 2002) DOI: 10.1046/j.1469-0691.8.s.2.8.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Results from the Amelioration of Use of β‐lactams and Pneumcococcal Resistance to Penicillin G Epidemiological Intervention (AUBEPPIN) Study in France [40]. This 5‐month study was conducted in children attending kindergartens within three geographically distinct populations. One population (Group 1) was subjected to educational interventions designed to reduce antibiotic use for upper respiratory tract infections (including the use of rapid diagnostic tests for group A streptococcal pharyngitis), one population (Group 2) was subjected to similar interventions designed to improve the dosage and duration of antibiotic therapy for these infections, and the other population (Group 3) received no intervention at all. (a) Decrease in antibiotic sales in Groups 1 and 2 compared with Group 3. (b) Regression coefficient for monthly reduction in rate of oropharyngeal colonization with penicillin‐resistant Streptococcus pneumoniae (PRSP) in each group. Clinical Microbiology and Infection 2002 8, 92-106DOI: (10.1046/j.1469-0691.8.s.2.8.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions